Insmed (INSM) Income Statement Analysis - Revenue, Earnings & Profitability Metrics - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Insmed

    NASDAQ: INSM · Real-Time Price · USD
    137.03
    1.44 (1.06%)
    At close: Sep 26, 2025, 3:59 PM
    135.00
    -1.48%
    After-hours: Sep 26, 2025, 07:28 PM EDT

    Insmed Income Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
    Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
    Revenue
    		 363.71M 305.21M 245.36M 188.46M
    Cost of Revenue
    		 85.74M 65.57M 55.13M 44.15M
    Gross Profit
    		 277.96M 239.63M 190.23M 144.31M
    Operating Income
    		 -878.25M -709.63M -478.12M -367.76M
    Interest Income
    		 n/a n/a 11.08M 174K
    Pretax Income
    		 -910.07M -747.01M -480.15M -436.41M
    Net Income
    		 -913.77M -749.57M -481.53M -434.65M
    Selling & General & Admin
    		 461.12M 344.5M 265.78M 234.27M
    Research & Development
    		 598.37M 571.01M 397.52M 272.74M
    Other Expenses
    		 96.73M 33.75M 5.05M 5.05M
    Operating Expenses
    		 1.16B 949.26M 668.36M 512.07M
    Interest Expense
    		 84.91M 81.69M 26.45M 40.47M
    Selling & Marketing Expenses
    		 n/a n/a 20.8M n/a
    Cost & Expenses
    		 1.24B 1.01B 723.48M 556.22M
    Income Tax Expense
    		 3.71M 2.56M 1.38M -1.76M
    Shares Outstanding (Basic)
    		 164.04M 140.43M 123.03M 112.11M
    Shares Outstanding (Diluted)
    		 164.04M 140.43M 123.03M 112.11M
    EPS (Basic)
    		 -5.57 -5.34 -3.91 -3.88
    EPS (Diluted)
    		 -5.57 -5.34 -3.91 -3.88
    EBITDA
    		 -814.14M -660.18M -429.44M -375.09M
    EBIT
    		 -829.81M -670.76M -457.7M -397.83M
    Depreciation & Amortization
    		 11.01M 10.58M 24.27M 27.85M

    Add to Watchlist